Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
Sponsor: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
This NA trial investigates End Stage Heart Disease and is currently ongoing. Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
13 versions recorded-
Dec 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
▶ Show 8 earlier versions
-
Jan 2023 — Nov 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2023 [monthly]
Recruiting NA
-
Dec 2019 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Dec 2019 [monthly]
Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- German Heart Institute
- Helmholtz Zentrum München
- University Medicine Greifswald
- University of Göttingen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bad Krozingen, Germany , Bad Nauheim, Germany , Bad Oeynhausen, Germany , Berlin, Germany , Erlangen, Germany , Frankurt Am Main, Germany , Göttingen, Germany , Hamburg, Germany , Hanover, Germany , Heidelberg, Germany and 7 more locations